These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2151661)
1. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci. Drabu YJ; Blakemore PH Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661 [TBL] [Abstract][Full Text] [Related]
2. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia. Shibl AM; Ishag AH; Durgham SM APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301 [TBL] [Abstract][Full Text] [Related]
3. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method. Thamlikitkul V J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906 [TBL] [Abstract][Full Text] [Related]
4. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. Chin NX; Neu HC Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330 [TBL] [Abstract][Full Text] [Related]
5. Concentration-dependent bacterial killing, adaptive resistance and post-antibiotic effect of ciprofloxacin alone and in combination with gentamicin. Gould IM; Milne K; Jason C Drugs Exp Clin Res; 1990; 16(12):621-8. PubMed ID: 2130004 [TBL] [Abstract][Full Text] [Related]
6. The post-antibiotic effects of linezolid against Gram-positive pathogens. Hosgor-Limoncu M; Ermertcan S; Tasli H; Aydemir S Saudi Med J; 2007 Apr; 28(4):551-4. PubMed ID: 17457476 [TBL] [Abstract][Full Text] [Related]
7. The post-antibiotic effect of teicoplanin: monotherapy and combination studies. Drabu YJ; Blakemore PH J Antimicrob Chemother; 1991 Apr; 27 Suppl B():1-7. PubMed ID: 1829074 [TBL] [Abstract][Full Text] [Related]
8. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Braga LC; Leite AA; Xavier KG; Takahashi JA; Bemquerer MP; Chartone-Souza E; Nascimento AM Can J Microbiol; 2005 Jul; 51(7):541-7. PubMed ID: 16175202 [TBL] [Abstract][Full Text] [Related]
9. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents]. Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259 [TBL] [Abstract][Full Text] [Related]
10. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Huang YT; Liao CH; Teng LJ; Hsueh PR Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671 [TBL] [Abstract][Full Text] [Related]
11. Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity. Nakashio S; Iwasawa H; Dun FY; Kanemitsu K; Shimada J Drugs Exp Clin Res; 1995; 21(1):7-16. PubMed ID: 7796712 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis. Van der Auwera P; Klastersky J Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species. Farrell DJ; Robbins M; Rhys-Williams W; Love WG Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci. Ravizzola G; Pirali F; Foresti I; Turano A Drugs Exp Clin Res; 1987; 13(4):225-9. PubMed ID: 2957187 [TBL] [Abstract][Full Text] [Related]
15. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. Pohlod DJ; Saravolatz LD; Somerville MM J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Garrison MW; Nuemiller JJ Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres. Gales AC; Sader HS; Jones RN Clin Microbiol Infect; 2005 Feb; 11(2):95-100. PubMed ID: 15679482 [TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates. Klietmann W; Focht J; Nösner K Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446 [TBL] [Abstract][Full Text] [Related]
20. Polyamine effects on antibiotic susceptibility in bacteria. Kwon DH; Lu CD Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]